Guangdong Simplifies Approval Procedures for Hong Kong- and Macao-Registered Traditional Chinese Medicines

Guangdong recently announced the simplification of registration approval procedures for Hong Kong- and Macao-registered traditional proprietary Chinese medicines intended for external use. The simplified procedures, which came into effect from 27 August, are intended to promote the integrated development of traditional Chinese medicine in the Guangdong-Hong Kong-Macao Greater Bay Area. The National Medical Products Administration has delegated oversight of approval procedures to provincial medical products administrations.